Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rang in aandelen #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aandeelprijs
$5.84
Laatst gesynchroniseerd: 2025-04-02
Marktkapitalisatie
$224.09M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Categorie

Healthcare
P/B-ratio voor Nevro Corp. (NVRO)
P/B-ratio op September 2026 TTM: 0.94
Volgens de meest recente financiële rapporten en aandelenkoers van Nevro Corp. is de huidige P/B-ratio (TTM) 0.94. Eind 2023 had het bedrijf een P/B-ratio van 2.64.
P/B-ratiohistoriek voor Nevro Corp. van 2012 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.94 56.27%
2024 0.60 -77.39%
2023 2.64 -38.83%
2022 4.32 -53.56%
2021 9.30 -38.04%
2020 15.01 -10.33%
2019 16.74 251.51%
2018 4.76 -41.60%
2017 8.15 -1.90%
2016 8.31 8.65%
2015 7.65 666.49%
2014 1.00 293.07%
2013 0.25 -35.33%
2012 0.39 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7633 301.38%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.1766 452.11%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 114.87%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2.8627 205.32%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9264 425.43%
US